Concepedia

Author

J. H. Bourhis

Institut Gustave Roussy

Also Known As

Bourhis, J.-H., Bourhis, Jean H, J H Bourhis, J. -H. Bourhis, J. H. Bourhis, J.-H. Bourhis, J.H Bourhis, J.H. Bourhis, Jean H. Bourhis, Jean Henri Bourhis

70

Publications

1K

Citations

16

H-Index

23

Concepts

All Affiliations

Institut Gustave RoussyHôpital Cardiologique du Haut-LévêqueInsermHôpital Saint-LouisHôpital Purpan
JH

About

J. H. Bourhis is an author at Institut Gustave Roussy specializing in hematology, medicine, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

200

2

Health Sciences

5

5

187

3

Immunology

4

4

107

4

Marrow Transplantation

2

2

71

5

Cellular Therapies

1

1

41

J. H. Bourhis

×

20

Publications

835

Citations

15

H-Index

YearCitations

Autologous and Allogeneic Stem-Cell Transplantation As Salvage Treatment of Acute Promyelocytic Leukemia Initially Treated With All-<i>Trans</i>-Retinoic Acid: A Retrospective Analysis of the European Acute Promyelocytic Leukemia Group

Stéphane de Botton, A Fawaz, Sylvie Chevret,

Journal of Clinical Oncology

2004

133

Hepatic veno-occlusive disease after myeloablative treatment and bone marrow transplantation: value of gray-scale and Doppler US in 100 patients.

Nathalie Lassau, J. Leclère, A. Aupérin,

Radiology

1997

122

Spectrum and prognosis of neurologic complications after hematopoietic transplantation

Christian Denier, J. H. Bourhis, C. Lacroix,

Neurology

2006

88

Long-term outcomes after reduced-intensity conditioning allogeneic stem cell transplantation for low-grade lymphoma: a survey by the French Society of Bone Marrow Graft Transplantation and Cellular Therapy (SFGM-TC)

S. Vigouroux, M. Michallet, Raphaël Porcher,

Haematologica

2007

82

Outcome of acute promyelocytic leukemia treated with all trans retinoic acid and chemotherapy in elderly patients: the European group experience

Lionel Adès, Sylvie Chevret, Stéphane de Botton,

Leukemia

2004

63

High survival rate with the LMT-89 regimen in lymphoblastic lymphoma (LL), but not in T-cell acute lymphoblastic leukemia (T-ALL)

Elias Jabbour, Serge Koscielny, Catherine Sebban,

Leukemia

2006

41

Lenalidomide as salvage treatment for multiple myeloma relapsing after allogeneic hematopoietic stem cell transplantation: a report from the French Society of Bone Marrow and Cellular Therapy

Téreza Coman, Emmanuel Bachy, M. Michallet,

Haematologica

2012

41

Activation of cytotoxic T-cell receptor    T lymphocytes in response to specific stimulation in myelodysplastic syndromes

Jean‐Jacques Kiladjian, Gian Paolo Visentin, Emilie Viey,

Haematologica

2008

39

Autologous peripheral-blood progenitor-cell support following high-dosechemotherapy or chemoradiotherapy in patients with high-risk multiple myeloma.

Gérald Marit, C. Fabères, J L Pico,

Journal of Clinical Oncology

1996

32

High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study

A. Ibrahim, E Zambon, J. H. Bourhis,

European Journal of Cancer

1993

30

Page 1